Early checkup and care program for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at early diagnosis and support for people with type 1 diabetes. You may be invited to participate if a parent or guardian agrees to enroll your child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A custodial parent (guardian) must sign a consent form
- You must have a custodial parent available to provide permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
This study tests a program that combines health education and motivational interviews for parents of children with type 1 diabetes. The goal is to help parents support their child's diabetes care and improve blood sugar control.
This study looks at infants to find how likely they are to develop type 1 diabetes later in life. If you have a newborn who is very young, you may be able to take part by allowing the study team to test them as part of early risk screening.
This study screens children aged 2 to 10 for early signs of type 1 diabetes using a simple blood test. Finding these signs early may help prevent or delay the disease.
This study checks for specific blood markers (“islet autoantibodies”) to find children who may be at risk for developing type 1 diabetes later, before symptoms start. It’s mainly for children who have no known diabetes yet.
This study helps clinics add a simple blood test to well-child visits to catch type 1 diabetes early, before symptoms appear. It also asks parents and clinic staff for feedback to make screening easier and more routine.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.